OF
RMD icon

Optimize Financial’s ResMed RMD Stock Holding History

Optimize Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$394K Buy
1,753
+202
+13% +$50.3K 0.19% 197
2025
Q4 		$374K Buy
1,551
+20
+1% +$5.12K 0.19% 224
2025
Q3 		$419K Buy
+1,531
New +$418K 0.22% 191

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Optimize Financial's RMD Position: Q1 2026 in Review

Optimize Financial increased its ResMed (RMD) stake by 13% in Q1 2026, buying an estimated $50.3K and bringing the position to 1,753 shares worth $394K. The position accounts for 0.19% of the portfolio, ranked #197.

Optimize Financial first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $419K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Optimize Financial held 1,753 shares of ResMed worth $394K as of Q1 2026.
  • Optimize Financial bought 202 ResMed shares in Q1 2026, an estimated $50.3K.
  • ResMed made up 0.19% of Optimize Financial's portfolio in Q1 2026, its #197 holding.
  • Optimize Financial first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • Optimize Financial's ResMed position peaked at $419K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Optimize Financial's 13F filing for Q1 2026, filed 12 May 2026.